One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial

JAMA Netw Open. 2023 May 1;6(5):e2312434. doi: 10.1001/jamanetworkopen.2023.12434.
No abstract available

Plain language summary

This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Letter

MeSH terms

  • Administration, Intravenous
  • Depression / drug therapy
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Humans
  • Ketamine* / therapeutic use

Substances

  • Ketamine
  • Excitatory Amino Acid Antagonists

Associated data

  • ClinicalTrials.gov/NCT03237286